NASDAQ
Apimeds Pharmaceuticals US, Inc (APUS) has a market cap of $16.32M as of Friday, May 22, 2026. The APUS market cap is up 590.40% over the past 30 days and has grown 764.94% over the past year. Market capitalization represents the total market value of a company's outstanding shares, calculated by multiplying the stock price by the total number of shares outstanding.
No price data available for this timeframe.